Phasei/II

Clinical trials for Phasei/II explained in plain language.

Never miss a new study

Get alerted when new Phasei/II trials appear

Sign up with your email to follow new studies for Phasei/II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New antibody combo targets tough lymphoma in early trial

Disease control Recruiting now

This study tests a new drug called EMB-07, which is a bispecific antibody that helps the immune system attack cancer cells. It is for people with aggressive B-cell non-Hodgkin lymphoma, either newly diagnosed or whose cancer has come back. The trial will check safety, side effect…

Matched conditions: PHASEI/II

Phase 1/2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control

Last updated Sep 03, 2026 00:00 UTC

Phasei/II

Get alerted when new Phasei/II trials appear

New antibody combo targets tough lymphoma in early trial